JPMorgan upgraded Procter & Gamble to Overweight from Neutral with a price target of $165, up from $157. The company is positioned to accelerate organic sales growth and improve margins in the medium term, the analyst tells investors in a research note. JPMorgan sees Procter & Gamble re-rating back to its historical valuation levels as a result. On Thursday’s earning call, the company gave reassurance that it is “on the right track,” contends the firm.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble Earnings Call: Growth Abroad, Strains at Home
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Procter & Gamble Posts Flat Q2 Results, Maintains 2026 Outlook
- Midday Fly By: GE Aerospace reports Q4 beat, P&G reports mixed Q2
- Procter & Gamble says remains confident in stronger growth in back half of year